novo nordisk weight loss

Order byBest matchMost fresh

Novo Nordisk to sell weight-loss drug for $499

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through multiple pharmacy platforms.

· 1d · on MSN

Ozempic creator Novo Nordisk will sell weight loss drugs for cheaper through this new partnership

· 13h · on MSN

Half-off Ozempic? US patients paying in cash can now buy the popular weight-loss drug for less

· 1d

U.S. patients can now get Ozempic for half price if they can pay cash

“While Ozempic is well covered in the US, let’s not forget that there are some patients who pay out-of-pocket for this vital medicine,” Dave Moore, executive vice president, of Novo Nordisk’s U.S. op...

· 21h

Health Matters: Health Canada approves Ozempic to help reduce kidney decline

· 1d

Canada approves Ozempic to cut risk of kidney failure, heart-related deaths

· 1d

US cash-paying customers can now get Ozempic for half price

The move comes as President Trump is pressuring drugmakers to lower drug costs.

· 1d

Inside the price war between Ozempic and other weight loss drugs

· 1d

Drugmaker halves price of Ozempic for Americans amid Trump crackdown

4hon MSN

Novo Nordisk’s New CEO Starts Hiring Freeze in Cost-Cutting Push

Novo Nordisk A/S said it has implemented a global hiring freeze as the Danish maker of weight-loss drugs seeks to cut costs and regain its footing in the competitive market.

Top pharma companies work to launch first weight-loss pill

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ever-growing popularity of Eli Lilly's Zepbound and Novo Nordisk's Wegovy.

2hon MSN

Novo Nordisk’s new CEO is said to start hiring freeze to cut costs

Novo Nordisk (NVO) reportedly implemented a global hiring freeze as the Danish drugmaker seeks to cut costs and regain its footing in the competitive market for weight-loss treatments.

1don MSN

Wegovy News Pushes Novo Nordisk Stock Higher

Novo Nordisk’s wildly popular GLP-1 drug Wegovy has been approved for use against a serious form of liver disease.

Study links injectable weight loss drugs to rare vision loss

The side effect is rare, according to a new study, but is also the subject of multiple lawsuits, including two filed by Long Island patients.